Genetic architecture of reciprocal CNVs

Current Opinion in Genetics and Development

Volumn 23, Issue 3, 2013, Pages 240-248

  Golzio, Christelle ^a   Katsanis, Nicholas ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIM KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PERIPHERAL MYELIN PROTEIN 22; TRANSCRIPTION FACTOR T BET;

CHROMOSOME ANALYSIS; COGNITIVE DEFECT; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; EPISTASIS; GENE DUPLICATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC RECOMBINATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOSITY; HUMAN; NONHUMAN; PENETRANCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPROCAL CHROMOSOME TRANSLOCATION; REVIEW; SEIZURE;

DNA COPY NUMBER VARIATIONS; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENETIC DISEASES, INBORN; GENETIC HETEROGENEITY; HUMANS; PHENOTYPE;

EID: 84879885338     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.04.013     Document Type: Review

References (118)

1. Redon R., et al. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
2. Iafrate A.J., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
3. Sebat J., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
4. McCarroll S.A., Altshuler D.M. Copy-number variation and association studies of human disease. Nat Genet 2007, 39:S37-S42.
5. Chen X., et al. Detection of copy number variants reveals association of cilia genes with neural tube defects. PLoS ONE 2013, 8:e54492.
6. Cooper G.M., et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011, 43:838-846.
7. Fakhro K.A., et al. Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proc Natl Acad Sci USA 2011, 108:2915-2920.
8. Greenway S.C., et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009, 41:931-935.
9. Osoegawa K., et al. Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J Med Genet 2008, 45:81-86.
10. Sanna-Cherchi S., et al. Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet 2012, 91:987-997.
11. Scott D.A., et al. Genome-wide oligonucleotide-based array comparative genome hybridization analysis of non-isolated congenital diaphragmatic hernia. Hum Mol Genet 2007, 16:424-430.
12. Serra-Juhe C., et al. Contribution of rare copy number variants to isolated human malformations. PLoS ONE 2012, 7:e45530.
13. Brunetti-Pierri N., et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008, 40:1466-1471.
14. Coe B.P., Girirajan S., Eichler E.E. The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet Part C: Semin Med Genet 2012, 160C:118-129.
15. Sanders S.J., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
16. Sebat J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
17. Stefansson H., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
18. Weiss L.A., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358:667-675.
19. McCarthy S.E., et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009, 41:1223-1227.
20. Kumar R.A., et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008, 17:628-638.
21. Abecasis G.R., et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
22. Krumm N., et al. Copy number variation detection and genotyping from exome sequence data. Genome Res 2012, 22:1525-1532.
23. Lupski J.R. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 1998, 14:417-422.
24. Lee J.A., Carvalho C.M., Lupski J.R. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 2007, 131:1235-1247.
25. Stankiewicz P., Lupski J.R. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002, 18:74-82.
26. Hannes F.D., et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 2009, 46:223-232.
27. Mefford H.C., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J. Med 2008, 359:1685-1699.
28. van Bon B.W., et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009, 46:511-523.
29. Ballif B.C., et al. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 2008, 1:8.
30. Lisi E.C., et al. 3q29 interstitial microduplication: a new syndrome in a three-generation family. Am J Med Genet A 2008, 146A:601-609.
31. Mulle J.G., et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet 2010, 87:229-236.
32. Willatt L., et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 2005, 77:154-160.
33. Lacaria M., et al. A duplication CNV that conveys traits reciprocal to metabolic syndrome and protects against diet-induced obesity in mice and men. PLoS Genet 2012, 8:e1002713.
34. Williams S.R., Zies D., Mullegama S.V., Grotewiel M.S., Elsea S.H. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet 2012, 90:941-949.
35. Crespi B., Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci 2008, 31:241-261. discussion 261-320.
36. Smith A.C., et al. Interstitial deletion of (17) (p11.2p11.2) in nine patients. Am J Med Genet 1986, 24:393-414.
37. Potocki L., et al. Molecular mechanism for duplication 17p11.2-the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet 2000, 24:84-87.
38. Potocki L., et al. Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am J Hum Genet 2007, 80:633-649.
39. Edelman E.A., et al. Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clin Genet 2007, 71:540-550.
40. Ricard G., et al. Phenotypic consequences of copy number variation: insights from Smith-Magenis and Potocki-Lupski syndrome mouse models. PLoS Biol 2010, 8:e1000543.
41. Sanchez-Valle A., Pierpont M.E., Potocki L. The severe end of the spectrum: hypoplastic left heart in Potocki-Lupski syndrome. Am J Med Genet A 2011, 155A:363-366.
42. Goh E.S., et al. Definition of a critical genetic interval related to kidney abnormalities in the Potocki-Lupski syndrome. Am J Med Genet A 2012, 158A:1579-1588.
43. Soler-Alfonso C., et al. Potocki-Lupski syndrome: a microduplication syndrome associated with oropharyngeal dysphagia and failure to thrive. J Pediatr 2011, 158:655-659. e652.
44. Wilson D.I., et al. DiGeorge syndrome with isolated aortic coarctation and isolated ventricular septal defect in three sibs with a 22q11 deletion of maternal origin. Br Heart J 1991, 66:308-312.
45. Carelle-Calmels N., et al. Genetic compensation in a human genomic disorder. N Engl J Med 2009, 360:1211-1216.
46. Driscoll D.A., et al. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992, 44:261-268.
47. Kobrynski L.J., Sullivan K.E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007, 370:1443-1452.
48. Ryan A.K., et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997, 34:798-804.
49. Scambler P.J. The 22q11 deletion syndromes. Hum Mol Genet 2000, 9:2421-2426.
50. Shprintzen R.J., et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 1978, 15:56-62.
51. Ensenauer R.E., et al. Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 2003, 73:1027-1040.
52. Portnoi M.F., et al. 22q11.2 duplication syndrome: two new familial cases with some overlapping features with DiGeorge/velocardiofacial syndromes. Am J Med Genet A 2005, 137:47-51.
53. Yobb T.M., et al. Microduplication and triplication of 22q11.2: a highly variable syndrome. Am J Hum Genet 2005, 76:865-876.
54. Sharp A.J., et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008, 40:322-328.
55. Sharp A.J., et al. Characterization of a recurrent 15q24 microdeletion syndrome. Hum Mol Genet 2007, 16:567-572.
56. Cook E.H., et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997, 60:928-934.
57. Dennis N.R., et al. Clinical findings in 33 subjects with large supernumerary marker(15) chromosomes and 3 subjects with triplication of 15q11-q13. Am J Med Genet A 2006, 140:434-441.
58. Helbig I., et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009, 41:160-162.
59. Miller D.T., et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 2009, 46:242-248.
60. Stone J.L., O.D.M., Gurling H., Kirov G.K., Blackwood D.H., Corvin A., Craddock N.J., Gill M. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
61. Shinawi M., et al. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 2009, 41:1269-1271.
62. Ait Yahya-Graison E., et al. Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. Am J Hum Genet 2007, 81:475-491.
63. Korenberg J.R., et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U S A 1994, 91:4997-5001.
64. Lupski J.R., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991, 66:219-232.
65. Patel P.I., et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992, 1:159-165.
66. Ionasescu V.V., et al. Severe Charcot-Marie-Tooth neuropathy type 1A with 1-base pair deletion and frameshift mutation in the peripheral myelin protein 22 gene. Muscle Nerve 1997, 20:1308-1310.
67. Valentijn L.J., et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992, 2:288-291.
68. Suter U., et al. Trembler mouse carries a point mutation in a myelin gene. Nature 1992, 356:241-244.
69. Chance P.F., et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993, 72:143-151.
70. Robaglia-Schlupp A., et al. PMP22 overexpression causes dysmyelination in mice. Brain 2002, 125:2213-2221.
71. Adlkofer K., et al. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 1997, 17:4662-4671.
72. Merscher S., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
73. Liao J., et al. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet 2004, 13:1577-1585.
74. Torres-Juan L., et al. Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation. Eur J Hum Gen: EJHG 2007, 15:658-663.
75. Zweier C., Sticht H., Aydin-Yaylagul I., Campbell C.E., Rauch A. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 2007, 80:510-517.
76. Yagi H., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003, 362:1366-1373.
77. Hiramoto T., et al. Tbx1: identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model. Hum Mol Genet 2011, 20:4775-4785.
78. Golzio C., et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 2012, 485:363-367.
79. Crepel A., et al. Narrowing the critical deletion region for autism spectrum disorders on 16p11.2. Am J Med Genet B Neuropsychiatr Genet 2011, 156:243-245.
80. Slager R.E., Newton T.L., Vlangos C.N., Finucane B., Elsea S.H. Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 2003, 33:466-468.
81. Girirajan S., et al. How much is too much? Phenotypic consequences of Rai1 overexpression in mice. Eur J Hum Genet: EJHG 2008, 16:941-954.
82. Bi W., et al. Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Hum Mol Genet 2007, 16:1802-1813.
83. Shimano H., et al. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 1996, 98:1575-1584.
84. Delio M., et al. Spectrum of elastin sequence variants and cardiovascular phenotypes in 49 patients with Williams-Beuren syndrome. Am J Med Genet A 2013.
85. Micale L., et al. Identification and characterization of seven novel mutations of elastin gene in a cohort of patients affected by supravalvular aortic stenosis. Eur J Human Genet: EJHG 2010, 18:317-323.
86. Frangiskakis J.M., et al. LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell 1996, 86:59-69.
87. Enkhmandakh B., et al. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development. Proc Natl Acad Sci U S A 2009, 106:181-186.
88. Morris C.A., et al. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet A 2003, 123A:45-59.
89. Ghebranious N., Giampietro P.F., Wesbrook F.P., Rezkalla S.H. A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation. Am J Med Genet A 2007, 143A:1462-1471.
90. Shinawi M., et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010, 47:332-341.
91. Ono S., et al. Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions. J Hum Genet 2012, 57:338-341.
92. Van der Aa N., et al. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur J Med Genet 2009, 52:94-100.
93. Ounap K., Laidre P., Bartsch O., Rein R., Lipping-Sitska M. Familial Williams-Beuren syndrome. Am J Med Genet 1998, 80:491-493.
94. Pankau R., et al. Familial Williams-Beuren syndrome showing varying clinical expression. Am J Med Genet 2001, 98:324-329.
95. Delio M., et al. Enhanced maternal origin of the 22q11.2 Deletion in velocardiofacial and digeorge syndromes. Am J Hum Genet 2013.
96. Szafranski P., et al. Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?. Hum Mutat 2010, 31:840-850.
97. Horev G., et al. Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc Natl Acad Sci USA 2011, 108:17076-17081.
98. Jacquemont S., et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 2011, 478:97-102.
99. Walters R.G., et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010, 463:671-675.
100. Girirajan S., et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012, 367:1321-1331.
101. Pinto D., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
102. Berg J.S., et al. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet Med 2007, 9:427-441.
103. Torniero C., et al. Dysmorphic features, simplified gyral pattern and 7q11.23 duplication reciprocal to the Williams-Beuren deletion. Eur J Human Genet: EJHG 2008, 16:880-887.
104. Wat M.J., et al. Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet A 2009, 149A:1661-1677.
105. Yu S., et al. Cardiac defects are infrequent findings in individuals with 8p23.1 genomic duplications containing GATA4. Circ Cardiovasc Genet 2011, 4:620-625.
106. Itsara A., et al. De novo rates and selection of large copy number variation. Genome Res 2010, 20:1469-1481.
107. Rosenfeld J.A., et al. Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. Genet Med 2010, 12:694-702.
108. Bonaglia M.C., et al. A 2.3Mb duplication of chromosome 8q24.3 associated with severe mental retardation and epilepsy detected by standard karyotype. Eur J Human Genet: EJHG 2005, 13:586-591.
109. Yatsenko S.A., et al. Deletion 9q34.3 syndrome: genotype-phenotype correlations and an extended deletion in a patient with features of Opitz C trigonocephaly. J Med Genet 2005, 42:328-335.
110. Bremer A., et al. Copy number variation characteristics in subpopulations of patients with autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 2011, 156:115-124.
111. Nagamani S.C., et al. Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Human Genet: EJHG 2011, 19:280-286.
112. Ramalingam A., et al. 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J Hum Genet 2011, 56:541-544.
113. Bi W., et al. Increased LIS1 expression affects human and mouse brain development. Nat Genet 2009, 41:168-177.
114. Roos L., et al. A new microduplication syndrome encompassing the region of the Miller-Dieker (17p13 deletion) syndrome. J Med Genet 2009, 46:703-710.
115. Toyo-oka K., et al. 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet 2003, 34:274-285.
116. Grisart B., et al. 17q21.31 microduplication patients are characterised by behavioural problems and poor social interaction. J Med Genet 2009, 46:524-530.
117. Kirchhoff M., Bisgaard A.M., Duno M., Hansen F.J., Schwartz M. A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features. Eur J Med Genet 2007, 50:256-263.
118. Koolen D.A., et al. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet 2008, 45:710-720.